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Background: Genomic analysis of bacteriophages infecting the Burkholderia cepacia complex (BCC) is an
important preliminary step in the development of a phage therapy protocol for these opportunistic pathogens.
The objective of this study was to characterize KL1 (vB_BceS_KL1) and AH2 (vB_BceS_AH2), two novel Burkholderia
cenocepacia-specific siphoviruses isolated from environmental samples.
Results: KL1 and AH2 exhibit several unique phenotypic similarities: they infect the same B. cenocepacia strains,
they require prolonged incubation at 30°C for the formation of plaques at low titres, and they do not form
plaques at similar titres following incubation at 37°C. However, despite these similarities, we have determined
using whole-genome pyrosequencing that these phages show minimal relatedness to one another. The KL1
genome is 42,832 base pairs (bp) in length and is most closely related to Pseudomonas phage 73 (PA73). In
contrast, the AH2 genome is 58,065 bp in length and is most closely related to Burkholderia phage BcepNazgul.
Using both BLASTP and HHpred analysis, we have identified and analyzed the putative virion morphogenesis, lysis,
DNA binding, and MazG proteins of these two phages. Notably, MazG homologs identified in cyanophages have
been predicted to facilitate infection of stationary phase cells and may contribute to the unique plaque
phenotype of KL1 and AH2.
Conclusions: The nearly indistinguishable phenotypes but distinct genomes of KL1 and AH2 provide further
evidence of both vast diversity and convergent evolution in the BCC-specific phage population.Background
The clinical administration of bacteriophages, referred to
as phage therapy, has now been used to treat bacterial
infections for nearly a century. Although this type of ther-
apy had been largely abandoned outside of Eastern Europe
since antibiotics became available in the 1940s, the emer-
gence of antibiotic-resistant pathogens has re-established
phage therapy as a viable antibacterial treatment [1]. Re-
cent studies have shown that phages and phage compo-
nents are effective both in animal models (against species
such as Staphylococcus, Pseudomonas, Klebsiella, Escheri-
chia, Salmonella, and Campylobacter) and in human clin-
ical trials [2-8]. Advances in phage delivery and storage
(such as nebulization, lyophilization, and spray drying for* Correspondence: jon.dennis@ualberta.ca
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reproduction in any medium, provided the orrespiratory phage therapy) and genomic characterization
(including high-throughput sequencing and annotation)
have made phage therapy more feasible with respect to
both logistics and safety [9-12].
One group of bacteria that is thought to be an excel-
lent target for phage therapy is the Burkholderia cepacia
complex (BCC). These bacterial species, which primarily
infect patients with cystic fibrosis (CF), are problematic
because they can cause serious illness (including, in up
to 20% of cases, a fatal necrotizing pneumonia referred
to as ‘cepacia syndrome’), they are capable of patient-
to-patient spread (particularly in settings such as CF cen-
ters), and, perhaps most importantly, they are highly
antibiotic resistant [13-16]. Very few antibiotics are active
against the BCC, even in combination: Zhou et al. [16]
tested a panel of antibiotics against BCC clinical isolates
and determined that less than half of the strains were
susceptible to even the most effective drugs. Clinically,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Development and morphology of KL1 and AH2
plaques. Phages were plated in half-strength Luria-Bertani (½ LB)
agar overlays with a 16 h liquid culture of Burkholderia cenocepacia
C6433. Plates were incubated at 30°C or 37°C and photographed
after 16, 24, and 48 h. C6433 30°C plates (center) are representative
of growth at both 30°C and 37°C.
Figure 2 KL1 (A) and AH2 (B) virion morphology. Phages were
stained with 2% phosphotungstic acid and visualized at 180,000-fold
magnification by transmission electron microscopy. Scale bars
represent 50 nm.
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deria multivorans and Burkholderia cenocepacia, with
the latter thought to be the most pathogenic [17]. BCC
phage therapy trials have focused on this species and, to
date, phages have been shown to be effective against B.
cenocepacia in both invertebrate and mammalian infec-
tion models [18-20].
As B. cenocepacia infections are some of the most
problematic for the CF community, the isolation and
characterization of novel phages that infect this species
remains a priority. Many of these phages have been iso-
lated in recent years, but only some have been fully
sequenced (reviewed in [21,22]). Here, we describe the
isolation and characterization of KL1 and AH2, two
novel B. cenocepacia-specific phages with identical host
ranges and unique growth characteristics, but strikingly
dissimilar genomes.
Results and discussion
Isolation, host range and morphology
KL1 was isolated from sewage using B. cenocepacia K56-
2 as a host. In contrast to enterobacteria phages, which
are commonly found in sewage [23], this is the first re-
port of BCC phage isolation from this source. AH2 was
isolated from Nandina sp. (also known as heavenly bam-
boo) soil using B. cenocepacia C6433. BCC phages have
commonly been isolated from both rhizospheres and soil
samples, including that of onion and Dracaena sp.
[18,20,24-27].
KL1 and AH2 are very similar with respect to both
host range and growth characteristics. These phages
have a relatively narrow tropism, infecting B. cenocepa-
cia K56-2, C6433, 715J, and K63-3. Both KL1 and AH2
exhibit a pattern of lysis that is unique in our collection
of BCC-specific phages: although high titre stocks of
these phages are very concentrated (up to 1011 plaque
forming units [PFU]/ml), these phages do not produce
clear lysis in agar overlays after 16 h incubation like
other phages that we have previously characterized
[18,19,26,28-30]. Instead, turbid or no clearing is
observed at high titres, with mottling or individual pla-
ques observed at lower titres (approximately 107 PFU/ml
or less). At low titres, incubation at 30°C for greater than
16 h is required for plaque formation, but plaques are
not observed if incubation is at 37°C (Figure 1). Individ-
ual plaques are turbid with a diameter of 0.5-2 mm (lar-
ger plaques may have a punctate appearance). When
tested with a panel of K56-2 mutants with progressive
deficiencies in lipopolysaccharide (LPS) structure (from
the O-antigen to the core) [31,32], both phages were
able to infect each mutant, suggesting that neither KL1
nor AH2 uses LPS as a major receptor.
Both KL1 and AH2 belong to the order Caudovirales
and family Siphoviridae as determined by electronmicroscopy. The KL1 virion has a non-contractile tail
approximately 160 nm in length and a capsid approxi-
mately 55 nm in diameter (Figure 2A). The AH2 virion
is slightly larger, with a non-contractile tail approxi-
mately 220 nm in length and a capsid approximately
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prising the tail structure are visible in the AH2 micro-
graph (Figure 2B).Genome characterization
Despite the similarities in phenotype between KL1 and
AH2 with respect to host range and growth characteris-
tics, the genomes of these two phages are dissimilar. Re-
striction fragment length polymorphism (RFLP) analysis
shows distinct banding patterns of EcoRI-digested KL1
and AH2 genomic DNA, suggesting that their sequences
are substantially different (Figure 3). This prediction is
confirmed by the results of whole genome pyrosequen-
cing (discussed below) and is illustrated in Figure 4A: in
a Circos plot of a PROmer comparison of these two
phages, no regions of similarity at the protein level are
observed under the parameters used.
The KL1 genome is 42,832 base pairs (bp) in length
and has a 54.6% GC content. This percentage is lower
than that for most Burkholderia-specific phages, which
tend to have GC contents between 60–65% (excluding
phages such as BcepB1A [54.5%], BcepF1 [55.9%], and
BcepGomr [56.3%]). We were unable to identify a KL1
cos site following incubation of the DNA at 80°C, as the
















Figure 3 RFLP analysis of KL1 and AH2 genomic DNA. 5 μg of
genomic DNA were digested overnight with EcoRI and separated on
a 0.8% agarose gel. The DNA in the ambient gel (left) was not
heated, while the DNA in the 80°C gel (right) was incubated 20 min
at 80°C and chilled on ice prior to loading. Arrows indicate bands
containing cos site DNA. L: 1 Kb Plus DNA Ladder (Invitrogen).heating (Figure 3). KL1 is predicted to encode 55 pro-
teins, all of which have an ATG start codon, except for
gp2 which has a GTG codon (Figure 5, Table 1).
KL1 is most similar to Pseudomonas phage 73 (PA73;
NC_007806), a siphovirus that infects Pseudomonas aer-
uginosa [33]. These phages are similar with respect to
genome length (42,999 bp for PA73 and 42,832 bp for
KL1), GC content (53.6% for PA73 and 54.6% for KL1),
and predicted number of proteins (52 for PA73 and 55
for KL1). BLASTN comparison of KL1 and PA73 indi-
cates that these sequences are similar over 69% of the
KL1 genome. KL1 encodes a protein most similar to
each PA73 protein from ORF001–ORF052 (excluding 12
proteins) (Table 1). Most PA73 proteins show limited
similarity to others in the NCBI database and have not
been assigned a putative function [33]. Of the 9 PA73
proteins with predicted functions, all but one (peptidyl-
tRNA hydrolase [peptide chain release factor]) is similar
to a KL1 protein: holin, terminase large subunit, head
morphogenesis protein, tail tape measure protein, DNA
polymerase, superfamily II helicase/restriction enzyme,
helicase (annotated here as recombinase), and dCMP
deaminase (KL1 gp2, gp7, gp9, gp21, gp27, gp30, gp33,
and gp52, respectively) (Table 1). Of the KL1 proteins
most similar to a PA73 protein, the most similar is gp33
(91% identity with ORF032) and the least similar is gp24
(36% identity with ORF023) (Table 1). In a Circos plot of
a PROmer comparison of these phages, the majority of
the two genomes are similar at the protein level
(Figure 4B).
The AH2 genome is 58,065 bp in length and has a
61.3% GC content. Incubation of the DNA at 80°C
caused a shift in the RFLP profile (Figure 3), suggesting
the presence of a cos site. Sequencing of the shifted frag-
ments indicates that AH2 has a 12 bp 5’ overhang cos
site with a sequence almost identical (1 bp difference) to
that of Burkholderia phage BcepNazgul (NC_005091).
AH2 is predicted to encode 78 proteins (Figure 5,
Table 2). The majority of the start codons (70) are ATG,
6 are GTG and 2 are TTG (Table 2).
AH2 is most similar to BcepNazgul, a siphovirus iso-
lated from soil that infects Burkholderia ambifaria. Like
PA73 and KL1, these phages are similar with respect to
genome length (57,455 bp for BcepNazgul and
58,065 bp for AH2), GC content (60.6% for BcepNazgul
and 61.3% for AH2), and predicted number of proteins
(73 for BcepNazgul and 78 for AH2). In contrast to KL1
(which is closely related to a single phage), AH2 encodes
proteins similar to those from a variety of bacteria and
phages (Table 2) and so is less closely related to Bcep-
Nazgul than KL1 is to PA73. BLASTN comparison of
AH2 and BcepNazgul indicates that these sequences are
similar over 16% of the AH2 genome. Twenty-one AH2
proteins are most similar to a BcepNazgul protein
Figure 4 Circos plots of KL1 and AH2 PROmer comparisons. Green ribbons indicate regions of similarity between two genomes at the
protein level. Each region is on the same strand in both genomes. The scale (in kbp) is shown on the periphery of the plots. PROmer parameters:
breaklen= 60, maxgap = 30, mincluster = 20, minmatch= 6. A) KL1/AH2 comparison; B) KL1/Pseudomonas phage 73 (PA73) comparison; C) AH2/
Burkholderia phage BcepNazgul comparison.
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analysis. Of the AH2 proteins most similar to a Bcep-
Nazgul protein, the most similar is gp12 (74% identity
with Nazgul10) and the least similar is gp20 (24% iden-
tity with Nazgul21) (Table 2). In a Circos plot of a PRO-
mer comparison of these phages, the most similar
regions at the protein level correspond to AH2 gp12,
gp71, gp78 (similar to BcepNazgul Nazgul10, helicase,
and DR0530-like primase, respectively) and a portion of




We have identified the proteins encoded by KL1 and
AH2 as belonging to four different functional categories:
virion morphogenesis (including capsid morphogenesis/
DNA packaging and tail morphogenesis), lysis, DNA
binding (the largest and broadest category), and MazG
(a pyrophosphohydrolase [34]). Although the proteins
encoded by each phage perform many of the same func-
tions (e.g. both KL1 gp11 and AH2 gp62 are predicted
to be major capsid proteins) (Tables 1 and 2), the pro-
teins themselves are dissimilar. As we discuss below, the
finding that KL1 and AH2 can create nearly identicalFigure 5 Genome maps of KL1 and AH2. Genes transcribed in the forwa
direction are shown below. The scale (in kbp) is shown below the maps. Le
packaging; pink, tail morphogenesis; red, DNA binding; green, MazG; gray,phenotypes with two dissimilar sets of proteins may be
compelling evidence for convergent evolution occurring
in these BCC-specific phages.
Virion morphogenesis
Although we have determined that KL1 is a siphovirus
(Figure 2A), the identity of many of the structural genes
remains unknown. As discussed above, KL1 is most
closely related to PA73, a phage whose proteins have
largely uncharacterized functions. Based on BLASTP
analysis, we have been able to predict the identity of only
eight KL1 structural proteins: three involved in capsid
morphogenesis and DNA packaging and five involved in
tail morphogenesis. Gp7 (terminase large subunit) and
gp9 (head morphogenesis protein) are similar to PA73
ORF006 and ORF008, respectively, both of which have
been assigned putative functions in the PA73 annotation
(Table 1). Gp11 (major capsid protein) is similar to the
major capsid proteins of Escherichia phage K1H and Lis-
tonella phage ϕHSIC. Gp20 is similar to tail proteins
from multiple Escherichia phages including K1G, K1H,
and K1ind1-K1ind3. Gp21 is predicted to be the tail tape
measure as it is the largest protein encoded by KL1
(1272 amino acids [aa]) and it is similar to the predicted
PA73 tape measure protein ORF020 (Table 1). Finally,rd direction are shown above and those transcribed in the reverse
gend: light blue, lysis; purple, capsid morphogenesis and DNA
unknown function.
Table 1 KL1 genome annotation














1 1 267 unknown + AGGGGCGAActtcgtATG 88 hypothetical protein ORF001 1-84/84 77 Pseudomonas phage 73 YP_001293408.1
2 264 560 holin + AAAGGGGCGGtaacGTG 98 hypothetical protein ORF002 3-88/88 42 Pseudomonas phage 73 YP_001293409.1
3 514 1080 lysin + AAAAGGGGttatcgaATG 188 hypothetical protein
bglu_1g27070
2-181/188 47 Burkholderia glumae BGR1 YP_002912484.1
4 1091 1408 Rz + AAGTAAGGGGttcgaaATG 105 hypothetical protein ORF004 1-101/101 37 Pseudomonas phage 73 YP_001293411.1
5 1329 1592 Rz1 + GAAAGGtgccgccgATG 87 conserved hypothetical protein 1-79/86 40 Burkholderia sp. Ch1-1 ZP_06842908.1
6 1647 2138 unknown + ACTAGGccgcgattATG 163 hypothetical protein ORF005 1-162/162 59 Pseudomonas phage 73 YP_001293412.1
7 2116 3756 terminase large
subunit
+ AACAGGAAttgcttaATG 546 hypothetical protein ORF006 10-531/531 84 Pseudomonas phage 73 YP_001293413.1
8 3770 5266 portal protein + AAAGGAAAcgaaatcATG 498 hypothetical protein ORF007 3-494/501 85 Pseudomonas phage 73 YP_001293414.1
9 5269 6384 head morphogenesis
protein
+ GGGGCGTAatcATG 371 hypothetical protein ORF008 1-364/364 73 Pseudomonas phage 73 YP_001293415.1
10 6403 7110 unknown + AAGGAGtccttgaaATG 235 hypothetical protein ORF009 1-235/239 82 Pseudomonas phage 73 YP_001293416.1
11 7123 8097 major capsid protein + AAGGAcactttatcATG 324 hypothetical protein ORF010 1-325/325 90 Pseudomonas phage 73 YP_001293417.1
12 8171 8587 unknown + AAGGAGtttcgaacATG 138 hypothetical protein ORF011 1-134/134 69 Pseudomonas phage 73 YP_001293418.1
13 8656 9033 unknown + AAAGGAGcgtcgaacATG 125 hypothetical protein ORF012 1-123/123 70 Pseudomonas phage 73 YP_001293419.1
14 9047 9565 unknown + AAGGGGcgcggcatcATG 172 hypothetical protein ORF013 1-172/172 83 Pseudomonas phage 73 YP_001293420.1
15 9570 9944 head-tail joining protein + GATAAGGGtctaacgctATG 124 hypothetical protein ORF014 1-124/126 59 Pseudomonas phage 73 YP_001293421.1
16 9941 10399 minor tail protein + ATACGGTAttgttcgcacaATG 152 hypothetical protein ORF015 5-151/151 68 Pseudomonas phage 73 YP_001293422.1
17 10412 11965 unknown + AAGGAGttacgaaaATG 517 hypothetical protein ORF016 3-511/511 78 Pseudomonas phage 73 YP_001293423.1
18 12030 12458 tail protein + GGAGTAAAccaaATG 142 hypothetical protein ORF017 1-142/142 79 Pseudomonas phage 73 YP_001293424.1
19 12030 12823 tail protein + GGAGTAAAccaaATG 264 hypothetical protein ORF017 1-142/142 79 Pseudomonas phage 73 YP_001293424.1
hypothetical protein ORF018 1-118/118 78 Pseudomonas phage 73 YP_001293425.1
20 12792 13226 tail protein + AAAAGGCGGcgcaacagaATG 144 hypothetical protein ORF019 1-144/144 80 Pseudomonas phage 73 YP_001293426.1
21 13232 17050 tail tape measure + AAGGAttagcagaaATG 1272 hypothetical protein ORF020 1-78, 131-
1202/1204
61, 57 Pseudomonas phage 73 YP_001293427.1
22 17069 18067 unknown + AGGAAtacgaattATG 332 hypothetical protein
XALc_0225
1-295/307 30 Xanthomonas albilineans
GPE PC73
YP_003374757.1
23 18070 19179 unknown + GAGGAAAActaatcATG 369 hypothetical protein ORF033 1-332/333 25 Pseudomonas phage M6 YP_001294541.1
24 19179 20870 tail assembly protein + AAGAAGAtcgcataATG 563 hypothetical protein ORF023 63-565/568 36 Pseudomonas phage 73 YP_001293430.1
25 20867 21688 tail assembly protein + AAGGAcgattccagaATG 273 hypothetical protein ORF024 1-273/274 49 Pseudomonas phage 73 YP_001293431.1



















Table 1 KL1 genome annotation (Continued)
27 24097 26166 DNA polymerase - AAGGAAtttgcccgATG 689 hypothetical protein ORF026 1-682/683 83 Pseudomonas phage 73 YP_001293433.1
28 26179 27339 DNA polymerase III
β subunit
- AAGGGGttaaaaATG 386 hypothetical protein ORF027 2-380/380 74 Pseudomonas phage 73 YP_001293434.1
29 27323 27691 unknown - GAATGGtgaaattATG 122 hypothetical protein Dole_2913 5-84/87 33 Desulfococcus oleovorans
Hxd3
YP_001530793.1
30 27696 29351 superfamily II
helicase/restriction
enzyme
- AAGGGttacgaATG 551 hypothetical protein ORF029 1-551/551 90 Pseudomonas phage 73 YP_001293436.1
31 29344 30342 exonuclease - GGAAGGcgaagaacgATG 332 hypothetical protein ORF030 1-365/365 65 Pseudomonas phage 73 YP_001293437.1
32 30852 31637 unknown - GAAAGGtgaaacgaacATG 261 hypothetical protein Isop_2441 1-118/151 37 Isosphaera pallida ATCC
43644
YP_004179564.1
33 31696 32412 recombinase - AGGTGAAcgtATG 238 hypothetical protein ORF032 1-238/238 91 Pseudomonas phage 73 YP_001293439.1
34 32471 32980 unknown - AAGGAAccccaaaATG 169 hypothetical protein ORF033 7-146/146 49 Pseudomonas phage 73 YP_001293440.1
35 33059 33598 pyrophosphohydrolase - AGGGGcatcgtATG 179 hypothetical protein ORF034 8-185/185 69 Pseudomonas phage 73 YP_001293441.1
36 33746 33934 transcriptional
regulator
+ GGGGcaagcATG 62 hypothetical protein ORF035 1-61/62 51 Pseudomonas phage 73 YP_001293442.1
37 33924 36233 primase + GAAGGcttgcgcaaatATG 769 hypothetical protein ORF036 1-773/773 85 Pseudomonas phage 73 YP_001293443.1
38 36366 36668 unknown + GAAGGAgttacgaacATG 100 hypothetical protein 132-217/217 44 Deftia phage ϕW-14 YP_003359005.1
39 36735 37091 unknown + GAAGGAGtacacgccATG 118 unnamed protein product 262-336/404 32 Azospirillum lipoferum 4B YP_004974060.1
40 37097 37360 unknown + AGAAGAAGGAGtaagcgccATG 87 PREDICTED: photosystem II
reaction center PSB28
protein, chloroplastic
22-86/179 32 Vitis vinifera XP_002271666.1
41 37728 38024 unknown + AAAGGAGcgccagccATG 98 hypothetical protein ORF039 1-97/98 70 Pseudomonas phage 73 YP_001293446.1
42 38060 38296 unknown + AAGGAAccccgatcATG 78 hypothetical protein ORF040 1-80/80 50 Pseudomonas phage 73 YP_001293447.1
43 38302 38703 unknown + AAAGGGGtaattactATG 133 hypothetical protein ORF042 1-120/124 40 Pseudomonas phage 73 YP_001293449.1
44 38707 39195 Vsr endonuclease + GACGAAGttgcattaagccATG 162 hypothetical protein ORF043 1-176/179 61 Pseudomonas phage 73 YP_001293450.1
45 39201 39458 unknown + GGAAGGAGtaacccaaATG 85 hypothetical protein
Astex_0306
3-81/183 44 Asticcacaulis excentricus
CB 48
YP_004086155.1
46 39455 39655 unknown + GGCGAAGtcgtcgaATG 66 monooxygenase, FAD-binding 385-445/546 38 Streptomyces griseoflavus
Tu4000
ZP_07309792.1
47 39652 39840 unknown + AAGGAGtacgcaccATG 62 hypothetical protein
METUNv1_00516
11-65/68 39 Methyloversatilis universalis
FAM5
ZP_08503515.1
48 39882 40154 unknown + AAAAGGAGtaacgaacATG 90 hypothetical protein
Cflav_PD2164
58-133/172 30 bacterium Ellin514 ZP_03630603.1
49 40138 40374 unknown + GAACCGGAttacgattATG 78 hypothetical protein
ORF047
2-77/77 67 Pseudomonas phage 73 YP_001293454.1



















Table 1 KL1 genome annotation (Continued)
hypothetical protein
Glaag_3667
Glaciecola sp. 4 H-3-7 +
YE-5
51 40562 40933 unknown + GAAAGGtgaaatcATG 123 hypothetical protein
BURMUCGD2M_4586
8-67/70 34 Burkholderia multivorans
CGD2M
ZP_03569237.1
52 40930 41415 dCMP deaminase + GGAACGtccggcATG 161 hypothetical protein ORF049 2-153/155 75 Pseudomonas phage 73 YP_001293456.1
53 41412 41786 unknown + AAAGGctgaatcATG 124 hypothetical protein ORF050 4-125/127 43 Pseudomonas phage 73 YP_001293457.1
54 41826 42032 unknown + GGGGAtgcccacattATG 68 hypothetical protein ORF051 37-94/94 45 Pseudomonas phage 73 YP_001293458.1



















Table 2 AH2 genome annotation














1 619 1035 unknown - AAGGAAAcgacATG 138 hypothetical protein
Nazgul32
12-130/130 29 Burkholderia phage BcepNazgul NP_918966.1
2 1073 1423 unknown - AGGGGGGAAcggccATG 116 conserved hypothetical
protein
1-116/116 72 Burkholderia multivorans CGD1 ZP_03586942.1
3 1501 1818 unknown - GGATTActgaccATG 105 family 2 glycosyl
transferase
292-387/387 32 Haloterrigena turkmenica
DSM 5511
YP_003404522.1
4 1809 2024 unknown + GAGAAAtagagATG 71 mobilization protein
mbeA
190-237/325 37 Escherichia coli E128010 EFZ49597.1
5 2021 2578 unknown - AGGGGttacatcATG 185 hypothetical protein
Nazgul06
88-158/330 44 Burkholderia phage BcepNazgul NP_919015.1
6 2728 2877 unknown - AGGTGcaaaaATG 49 hypothetical protein
BoklE_20935
6-38/38 48 Burkholderia oklahomensis EO147 ZP_02357945.1
7 2874 3002 unknown - AGGGGcgatcATG 42 polysaccharide deacetylase 21-60/287 35 Bacillus mycoides Rock3-17 ZP_04156726.1
8 3071 3325 unknown - AAAGAgctATG 84 major facilitator
superfamily MFS_1
131-209/467 37 Burkholderia gladioli BSR3 YP_004349464.1
9 3322 3579 unknown - GGAGTAtccgccATG 85 hypothetical protein
Plabr_1809
308-361/603 31 Planctomyces brasiliensis
DSM 5305
YP_004269441.1
10 3663 3911 unknown - GGGGGTAtgacATG 82 HAD-superfamily
hydrolase
70-119/268 38 Methanosphaerula palustris E1-9c YP_002465429.1
11 3913 4314 unknown - AGGGGGAGtaacggccATG 133 hypothetical protein
Nazgul09
1-129/141 59 Burkholderia phage BcepNazgul NP_919018.1
12 4320 4805 unknown - AGGGGttacatcATG 161 hypothetical protein
Nazgul10
1-151/160 74 Burkholderia phage BcepNazgul NP_919019.2
13 4846 5454 unknown - AAAAAGGGGtttttgacATG 202 194 gene product 101-187/188 43 Salmonella phage PVP-SE1 YP_004894001.1
14 6021 6302 unknown + AAGGAGcaatcATG 93 hypothetical protein
Nazgul13
3-93/93 41 Burkholderia phage BcepNazgul NP_919022.1
15 6311 6550 unknown + AGGCGGtcgtATG 79 hypothetical protein
BDB_mp60418
1-67/67 45 blood disease bacterium R229 CCA83252.1
16 6707 7015 unknown + ACACGAcaccATG 102 hypothetical protein
MC7420_4162
43-84/88 45 Microcoleus chthonoplastes
PCC 7420
ZP_05027813.1
17 7012 7218 unknown + GAAGGtgccggcATG 68 hypothetical protein
Cy51472DRAFT_4929
53-81/152 45 Cyanothece sp. ATCC 51472 ZP_08976132.1
18 7215 8069 unknown + AGGAAAGgaaATG 284 hypothetical protein
TK90_2682
5-175/177 45 Thioalkalivibrio sp. K90mix YP_003494636.1
19 8123 8407 unknown + GAGAAGGcacacacATG 94 GTP-binding protein 150-232/1016 29 Gemmata sp. Wa1-1 AAX07516.1
20 8499 9128 DNA polymerase
III β subunit
+ GAACGGTGAGcttATG 209 hypothetical protein
Nazgul21



















Table 2 AH2 genome annotation (Continued)
21 9149 9343 unknown + AGGAGAAAGgagATG 64 hypothetical protein
R2APBS1DRAFT_0277
9-63/344 31 Rhodanobacter sp. 2APBS1 ZP_08951135.1
22 9346 9645 unknown + GGGGGTAtctgaccATG 99 hypothetical protein
PFL_2108
3-63/70 33 Pseudomonas fluorescens Pf-5 YP_259216.1
23 9642 9938 unknown + GGAGGGtcaTTG 98 aspA gene product 38-122/317 32 Rhodospirillum centenum SW YP_002297975.1
24 9935 10171 unknown + GGGGcttggcgtATG 78 hypothetical protein
Nazgul19
18-97/97 39 Burkholderia phage BcepNazgul NP_919028.2
25 10256 10711 pyrophosphohydrolase + AAGGAAAggacATG 151 hypothetical protein
BCAS0549
15-139/140 60 Burkholderia cenocepacia J2315 YP_002153936.1
26 10720 10977 unknown + GAGGccggccATG 85 hypothetical protein
AGRO_3677
208-273/300 41 Agrobacterium sp. ATCC 31749 ZP_08529674.1
27 11082 12074 unknown + AGGAGAAatcGTG 330 hypothetical protein 8-95/113 48 Escherichia phage
vB_EcoM_ECO1230-10
ADE87960.1
28 12101 13075 transcriptional
regulator





29 13078 13497 unknown + GCTGACGAtctctgaccATG 139 hypothetical protein
SCHCODRAFT_69044
549-631/848 33 Schizophyllum commune H4-8 XP_003030158.1
30 13574 13768 transcriptional
regulator
+ AGGGAtttttcATG 64 hypothetical protein
APT_2164
9-65/75 53 Acetobacter pasteurianus
NBRC 101655
GAB28674.1
31 13768 14031 transcriptional
regulator
+ AAGCGGAGccgtcctgATG 87 hypothetical protein
Bcep1808_2468
2-85/86 73 Burkholderia vietnamiensis G4 YP_001120302.1
32 14064 14450 Vsr endonuclease - GGAGGAatgATG 128 DNA mismatch
endonuclease Vsr
15-141/141 65 Methylocella silvestris BL2 YP_002360880.1
33 14450 15025 excinuclease - AACAGAGttgcagcGTG 191 Excinuclease ABC C
subunit domain protein
3-183/192 58 Pseudomonas syringae pv.
lachrymans str. M301315
EGH83133.1
34 15038 15892 restriction
endonuclease
- GGCAAAGGtcgccgcATG 284 conserved hypothetical
protein
1-285/285 70 Ralstonia solanacearum CMR15 CBJ36134.1
35 15889 17031 cytosine
methylase
- AGGGGGttcgcGTG 380 DNA-cytosine
methyltransferase
1-385/385 66 Ralstonia solanacearum CMR15 CBJ36133.1
36 17107 17199 unknown + ACGAAGccttgcttaATG 30 resistance-nodulation-cell
division acriflavin:proton
(H+) antiporter
850-868/1014 68 Bacillus pumilus SAFR-032 YP_001486844.1
37 17511 18842 integrase + GAAGGAGGtcttgtagcactgATG 443 chorismate mutase
family protein
1-362/386 62 Phaeobacter gallaeciensis BS107 ZP_02147383.1
38 18990 19412 unknown + AAGGAGGAatcATG 140 hypothetical protein
Dda3937_00584
60-163/163 40 Dickeya dadantii 3937 YP_003882998.1
39 19462 20001 unknown - GGAGAttttcATG 179 hypothetical protein
PcarcW_20243
68-197/198 67 Pectobacterium carotovorum
subsp. carotovorum WPP14
ZP_03833564.1
40 20034 20264 Rz1 - GGAGGAcgccATG 76 hypothetical protein
BURPS668_A2333



















Table 2 AH2 genome annotation (Continued)
41 20277 20588 Rz - AGGGGGccgtATG 103 hypothetical protein
ORF004
2-101/101 35 Pseudomonas phage 73 YP_001293411.1
42 20585 21091 lysin - AAGGAGAAGAacaGTG 168 hypothetical protein
HMPREF0005_02034
1-161/163 60 Achromobacter xylosoxidans C54 EFV83908.1
43 21088 21339 holin - GAAGGGGtggacccgaccATG 83 conserved exported
hypothetical protein
1-83/85 35 blood disease bacterium R229 CCA83792.1
44 21336 21665 unknown - AAGGGGccagaagATG 109 hypothetical protein
HDEF_1702
3-87/92 31 Candidatus Hamiltonella defensa
5AT (Acyrthosiphon pisum)
YP_002924457.1
45 21807 22121 unknown - AAGGAGAAAtcacATG 104 hypothetical protein
PPL19_05085
1-103/161 53 Pseudomonas psychrotolerans L19 ZP_09283635.1
46 22133 23731 tail fiber protein - GGAACGtggacATG 532 hypothetical protein
Bpse112_32291
69-240/282 45 Burkholderia pseudomallei 112 ZP_02502292.1
47 23809 26178 tail assembly protein - AGAGGAAGAcaaATG 789 hypothetical protein
HCH_05649
2-727/728 34 Hahella chejuensis KCTC 2396 YP_436732.1
48 26175 26375 tail assembly protein - GGGGGCAAgaaATG 66 hypothetical protein
HCH_05650
4-67/71 50 Hahella chejuensis KCTC 2396 YP_436733.1
49 26372 26608 tail assembly protein - GAGGActgatcATG 78 putative transmembrane
protein
7-82/82 47 Rhodobacter sp. SW2 ZP_05845047.1
50 26618 27418 tail assembly protein - AGGGGGAtcaaacaATG 266 hypothetical protein
HCH_05652
1-268/269 39 Hahella chejuensis KCTC 2396 YP_436735.1
51 27415 29100 tail assembly protein - AAGAAGAtcacTTG 561 hypothetical protein
HCH_05654
35-560/563 32 Hahella chejuensis KCTC 2396 YP_436736.1





53 30160 31122 unknown - GAGCGAGGcataacGTG 320 hypothetical protein
XALc_0225
1-194/307 35 Xanthomonas albilineans
GPE PC73
YP_003374757.1
54 31124 35860 tail tape measure - GGACTGAAcggaaATG 1578 phage tape measure
protein
1-109, 452-1680/1683 33 Sinorhizobium meliloti AK83 YP_004548730.1
55 35853 36538 tail protein - AAGGGGGCGagcATG 228 pre-tape measure
frameshift protein G-T
1-242/243 34 Burkholderia phage BcepNazgul NP_918998.2
56 36098 36538 tail protein - AAGGGGGCGagcATG 146 hypothetical protein
Sinme_1368
4-126/142 34 Sinorhizobium meliloti AK83 YP_004548729.1
57 36549 37337 unknown - GAGGAAtcaatcATG 262 hypothetical protein
Sinme_1367
1-257/262 45 Sinorhizobium meliloti AK83 YP_004548728.1
58 37385 37897 minor tail protein - GAGGAAAGtataATG 170 hypothetical protein
Sinme_1366
7-177/177 50 Sinorhizobium meliloti AK83 YP_004548727.1
59 37897 38517 unknown - GACGCAGGtttgccgacATG 206 hypothetical protein
Nazgul55
5-198/205 49 Burkholderia phage BcepNazgul NP_918988.2
60 38514 38873 unknown - GAGGCGcgtgATG 119 hypothetical protein
Sinme_1364



















Table 2 AH2 genome annotation (Continued)
61 38886 39134 unknown - AAAGGAAccatcATG 82 hypothetical protein
Nazgul57
1-38/85 47 Burkholderia phage BcepNazgul NP_918990.1
62 39205 40233 major capsid protein - AAGGAGAAAGcaaaATG 342 capsid protein E 2-343/346 50 Burkholderia phage BcepNazgul NP_918991.1
63 40290 40688 decorator protein - AGGAGAAccatcATG 132 decorator protein D 4-123/131 49 Burkholderia phage BcepNazgul NP_918992.1
64 40743 42071 prohead protease - AGGACCAGAAccaATG 442 prohead protease ClpP 4-427/434 53 Burkholderia phage BcepNazgul NP_918994.2
65 42068 43591 portal protein - GGAAcccgtcgATG 507 phage portal protein 57-554/559 59 Staphylococcus phage SA1 ACZ55505.1
66 43736 43960 head-tail joining protein - GGACAAcactATG 74 head-tail joining protein
Lambda W
13-76/76 56 Burkholderia phage BcepNazgul NP_918996.1
67 44097 46076 terminase large subunit - AAGAcctcgATG 659 terminase large
subunit TerL
44-677/677 58 Burkholderia phage BcepNazgul NP_918997.2
68 46210 46803 terminase small subunit - GAAGGTGAtagcgATG 197 TerS 9-179/222 49 Burkholderia phage BcepNazgul NP_918999.1
69 46796 46990 transcriptional regulator - AGGAGTAcggtATG 64 aminoglycoside
phosphotransferase
423-473/487 29 Frankia sp. EUN1f ZP_06416368.1
70 47047 47736 repressor - GAAAGGCAAGGcagcagcATG 229 hypothetical protein
Rvan_1213
14-180/242 36 Rhodomicrobium vannielii
ATCC 17100
YP_004011581.1
71 47833 49446 helicase - ACGAcctcctgcgATG 537 helicase 11-507/522 52 Burkholderia phage BcepNazgul NP_919000.2
72 49443 49745 resolvase - GAAAGGAGGAttcactGTG 100 conserved phage
protein
15-103/108 55 Burkholderia phage BcepNazgul NP_919001.2
73 49742 51796 DNA polymerase - ACGTcaccATG 684 hypothetical protein
ORF026
48-670/683 45 Pseudomonas phage 73 YP_001293433.1
74 51875 52609 single-stranded DNA
binding protein
- AAAGGTGAcaaaaATG 244 conserved phage
protein
4-186/198 35 Staphylococcus phage SA1 ACZ55548.1
75 52655 53995 Cas4 superfamily
exonuclease
- GATCctctcgaccccATG 446 conserved phage
protein
8-448/454 48 Burkholderia phage BcepNazgul NP_919005.2
76 54140 54538 unknown - GGAGAAatcATG 132 hypothetical protein
RUMHYD_01446
1-120/122 26 Blautia hydrogenotrophica
DSM 10507
ZP_03782010.1
77 54718 55017 Cro + AACGGAGAtcacaATG 99 hypothetical protein
Nazgul73
5-90/97 31 Burkholderia phage BcepNazgul NP_919007.1



















Figure 6 Sequences of the KL1 and AH2 predicted translational
frameshift sites. For each phage, the first row shows the DNA
sequence (with the predicted frameshift site underlined); the second
row shows the amino acid sequence in the original frame (the KL1
gp18 stop codon is represented by an asterisk); the third row shows
the amino acid sequence in the −1 frame; the fourth row shows the
amino acid sequence of the frameshifted protein.
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teins. Using HHpred analysis, we were able to identify
an additional three proteins at a probability threshold of
75%. Gp8 is similar to bacteriophage SPP1 portal protein
(99.44% probability), gp15 is similar to λ gpFII head-tail
joining protein (82.86% probability), and gp16 is similar
to λ gpU minor tail protein (77.70% probability) (Add-
itional file 1: Table S1).
In comparison with KL1, the structural proteins of
AH2 are well defined. Genes 62–68 make up the capsid
morphogenesis and DNA packaging module, containing
genes encoding the major capsid protein, decorator pro-
tein, prohead protease, portal protein, head-tail joining
protein, and terminase subunits (large and small)
(Table 2). Each of these proteins is similar to a BcepNaz-
gul protein, with percent identities between 49-58%. Sev-
eral genes between 47 and 56 are similar to genes
encoding BcepNazgul conserved tail assembly proteins,
tape measure protein, and pre-tape measure frameshift
protein G-T (with percent identities between 26-38%).
Two additional AH2 tail proteins were identified using
BLASTP (gp46, similar to Pseudomonas psychrotolerans
L19 phage tail fiber protein) or HHpred (gp58, similar to
λ gpU minor tail protein) analysis (Additional file 2:
Table S2). Hypothetical proteins encoded in this region
are likely to be involved in tail morphogenesis based on
the proximity of their genes to this module.
Most tailed phages encode two tail proteins proximal
to the tail tape measure gene by way of a −1 transla-
tional frameshift [35]. We have previously identified
these frameshifted genes in the BCC-specific phages
KS9, KS5, KS14, and KL3 [19,29]. Using FSFinder and
manual scanning for XXXYYYZ motifs, we predict that
KL1 gp18/gp19 and AH2 gp55/gp56 are expressed using
this mechanism. The predicted frameshift site in KL1 is
GGGAAAC, immediately upstream of the gp18 TGA
stop codon (Figure 6 and Additional file 3: Figure S3).
A −1 ribosomal shift following the terminal C will allow
for expression of the 264 aa gp19 and the 142 aa gp18
from the same start codon (Figure 6). Although mostphages encode their frameshifted proteins immediately
upstream of the tail tape measure gene, KL1 encodes an
intervening tail protein, gp20 (Table 1, Figure 5). This
organization is similar to that of Escherichia coli phage
HK97, Bacillus subtilis phage SPP1, Methanobacterium
thermoautotrophicum phage ψM2, Methanothermobac-
ter wolfei phage ψM100, Lactococcus phages c2 and
BIL67, and Natrialba magadii phage ϕch1 [35]. The
predicted frameshift site in AH2 is AAAAAAG (Figure 6
and Additional file 3: Figure S3), the same sequence
used by E. coli phage VT1-Sakai, M. thermoautotrophi-
cum phage ψM2, Staphylococcus aureus phages PVL
and PV83, Lactococcus lactis phage ul36, and Borrelia
burgdorferi prophage Borreliapro [35]. In the case of
AH2, a −1 shift of the ribosome following the G in this
sequence will allow for the 228 aa gp55 to be expressed
instead of the 146 aa gp56 (Figure 6). Using BLASTP or
HHpred searches, we were unable to identify the KL1 or
AH2 major tail proteins. However, we predict that
these proteins may be gp17 in KL1 and gp57 in AH2
as the major tail genes are generally positioned upstream
of the frameshifted protein genes [35]. Although not
present in all sequences, RNA secondary structures are
often found downstream of frameshift sites [19,29,35,36].
Mfold analysis of the 35 bases downstream of the puta-
tive KL1 and AH2 sites suggests that stem-loop struc-
tures could form in both of these regions (Additional file
3: Figure S3).
Lysis
In KL1, we have identified the genes putatively encoding
the holin, lysin, Rz and Rz1 lysis proteins. In a BLASTP
search, gp2 shows similarity to putative holin proteins of
PA73 and BcepNazgul. TMHMM analysis of this protein
indicates that it has two transmembrane domains, so
gp2 is predicted to be a class II holin [37]. Gp3 is similar
to the endolysin of Erwinia phage vB_EamP-S6
(HQ728266) and contains lysozyme and peptidoglycan-
binding conserved domains. Although gp4 does not
show similarity to any Rz proteins in the NCBI database,
it is predicted to contain a single N-terminal transmem-
brane domain, characteristic of Rz proteins [38]. Gp5 is
predicted to be the KL1 Rz1 protein as it is similar to
BcepNazgul Rz1 and LipoP analysis identifies a signal
peptidase II cleavage site between positions 17 and 18
(resulting in a 70 aa protein with 4 proline residues
[5.7% proline]). The proportion of prolines in the pre-
dicted Rz1 lipoprotein is low compared to previously
identified Rz1 proteins in BCC phages [19,29,39].
The same lysis proteins were identified in AH2. Like
KL1 gp2, the putative AH2 holin gp43 is similar to the
BcepNazgul holin, has two transmembrane domains,
and is predicted to be a class II holin. Although gp42
shows no similarity to endolysins in a BLASTP search,
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and prokaryotic lysozyme proteins. Gp41 is predicted to
be the AH2 Rz protein as it has a single N-terminal
transmembrane domain. Although manual annotation
has been required for identification of the Rz1 gene in
KL1 and in our previous studies [19,29], we predict that
the GeneMark-assigned gp40 is the AH2 Rz1 protein.
Gp40 is similar to BcepNazgul Rz1 and has a signal pep-
tidase II cleavage site between amino acids 15 and 16.
Similar to the predicted KL1 Rz1, the proportion of pro-
lines present in this protein is relatively low (3/61 or
4.9%). It is unclear from this analysis what protein(s)
may contribute to the unique plaque phenotype
observed in both of these phages. Aside from the low
proportion of proline found in the putative Rz1 proteins,
KL1 and AH2 appear to have relatively standard lysis
modules, suggesting that unique (and as yet unidenti-
fied) proteins may be responsible for controlling lysis
timing in each phage.
DNA binding
Of the 8 KL1 proteins similar to a PA73 protein with an
assigned function, half of these are DNA- or nucleotide-
binding proteins: DNA polymerase (gp27), superfamily
II helicase/restriction enzyme (gp30), helicase (annotated
here as recombinase [gp33]), and dCMP deaminase
(gp52) (Table 1). In addition, KL1 encodes a putative
DNA polymerase III β subunit (gp28), exonuclease
(gp31), transcriptional regulator (gp36), primase (gp37),
and Vsr endonuclease (gp44) (Table 1 and Additional file
1: Table S1). In a multi-genome analysis performed by
Lopes et al. [40], it was determined that PA73 ORF032 is
distantly related to Lactococcus phage ϕ31 Sak4 recom-
binase. When this protein was expressed in E. coli, it
exhibited recombinase activity, but was found to be less
efficient than λ Redβ [40]. Furthermore, PA73 encodes
an exonuclease, as is found in characterized phage re-
combinase pairs such as Redαβ in λ and RecET in rac
[40]. KL1 gp33 is most closely related to PA73 ORF032
and, with 91% identity, is the KL1 protein most similar
to a PA73 protein. In addition, KL1 gp31 has 65% iden-
tity with PA73 ORF030 and both of these proteins are
similar to λ Redα (99.21% probability for gp31 and
99.17% probability for ORF030) (Table 1 and Additional
file 1: Table S1). It is interesting to note that, despite the
relatively limited similarity between KL1 and other pre-
viously sequenced BCC-specific phages, both gp31 and
gp33 are similar to proteins from Burkholderia phage
BcepGomr (BcepGomrgp43 and BcepGomrgp45, re-
spectively) [40]. Although further characterization of
these proteins is required in both KL1 and BcepGomr, it
is possible that these exonucleases and Sak4-like recom-
binases represent a conserved recombination system in
certain BCC-specific phages.AH2 encodes DNA replication, modification, and re-
pair proteins including a putative DNA polymerase III β
subunit (gp20), Vsr endonuclease (gp32), excinuclease
(gp33), restriction endonuclease/methylase pair (gp34/
gp35), integrase (gp37), helicase (gp71), resolvase (gp72),
DNA polymerase (gp73), single-stranded DNA binding
protein (gp74), Cas4 superfamily exonuclease (gp75),
and primase (gp78) (Table 2). Other putative DNA bind-
ing proteins are predicted to be involved in transcrip-
tional regulation. Gp28 is similar to partitioning and
regulation proteins from Thermus thermophilus (100%
probability) and E. coli (99.86% probability) (Additional
file 2: Table S2). The gp30 and gp31 predicted proteins
belong to the helix-turn-helix MerR superfamily and the
pyocin activator superfamily, respectively. Both of these
proteins, in addition to gp69, also show similarity to
excisionase proteins (Additional file 2: Table S2). Gp70
and gp77 are similar to the lysogeny control proteins CI
from enterobacteria phage 186 (99.87% probability) and
Cro from Xylella fastidiosa Ann-1 (96.60% probability),
respectively (Additional file 2: Table S2).
AH2 gp32-gp35 are predicted to be part of a DNA
protection and repair module. Vsr (very short patch re-
pair) endonucleases are involved in the repair of 5-
methylcytosine to thymine deamination [41]. Previously,
we identified a Vsr endonuclease in the BCC-specific
phage KL3 that, along with an EcoRII-C endonuclease/
methylase pair, was predicted to be part of a novel non-
self DNA degradation and self DNA protection/repair
module [29]. Our model proposed that non-KL3 DNA
(i.e. that of the host or a superinfecting phage) would be
degraded by the endonuclease (gp45), while KL3 DNA
would be protected by the methylase (gp47) (converting
cytosine to 5-methylcytosine). Vsr endonuclease (gp46)
and very short patch repair would then prevent the ac-
cumulation of mutations caused by 5-methylcytosine de-
amination [29].
The DNA protection and repair system of AH2 is
analogous to that of KL3. AH2 gp32 has 51% identity
with the KL3 Vsr endonuclease and is similar to E. coli
Vsr endonuclease (100% probability) (Additional file 2:
Table S2). AH2 also encodes an endonuclease/methylase
pair: gp34 is similar to Kluyvera ascorbata KasI (64%
identity) while gp35 is similar to K. ascorbata M.KasI,
Brevundimonas diminuta ATCC 11568 cytosine-specific
methyltransferase NlaX, and Acetobacter pomorum
DM001 modification methylase HpaII (63-66% identity).
Gp35 also has several methylase conserved domains, in-
cluding Dcm (an enzyme that produces 5-methylcytosine
bases at sites recognized by Vsr endonuclease) [41].
Gp33 is similar to Thermotoga maritima UvrABC sys-
tem protein C (98.35% probability) and could function
together with UvrAB in nucleotide excision repair
(Additional file 2: Table S2) [42]. Although further
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of gp34 and gp35, we predict that this module may func-
tion as follows: gp34 cleaves non-self DNA, while self
DNA is protected by gp35 methylation and subsequent
gp32 repair (with gp33 participating in nucleotide exci-
sion repair). Although the identity and arrangement of
genes in this module is different in AH2 than in KL3,
the identification of a similar module in an unrelated
BCC-specific phage suggests that these genes may be
widely used for DNA protection and repair in this group
of viruses.
MazG
A notable protein encoded by both KL1 and AH2 is
MazG. MazG is a pyrophosphohydrolase that acts on
ppGpp, one of the signaling molecules in bacteria pro-
duced during the stringent response [43]. When bacter-
ial cells are in an amino acid-limited environment, RelA
synthesizes pppGpp, the precursor of ppGpp, and the
latter activates the expression of genes required for cell
survival (such as rpoS) and represses genes required for
protein and DNA synthesis (reviewed in [44]). Recently,
there has been a great deal of interest in marine phages
(especially cyanophages) that encode MazG homologs,
such as Prochlorococcus phages P-SSM2 and P-SSM4,
Synechococcus phage S-PM2, Prochlorococcus and Syne-
chococcus phage Syn9, Roseobacter phage SIO1, Pseu-
doalteromonas phage H105/1, almost one-fifth of the
cyanophages tested by Bryan et al. [45], and all of the
cyanophages analyzed by Sullivan et al. [46] [47-51]. It
has been suggested that these MazG-encoding phages
are better able to infect and propagate within their hosts,
which are found in nutrient-limited water. By inactivat-
ing ppGpp, these phages can promote the expression of
genes that would usually be expressed by an exponential
phase cell under nutrient-rich conditions, such as those
required for protein and DNA synthesis [52]. There are
few published reports of the mazG gene in non-marine
phages, but it has been previously identified in Myxococ-
cus phage Mx8 and mycobacteriophage L5 [45].
The putative MazG proteins encoded by KL1 and
AH2 are gp35 and gp25, respectively. KL1 gp35 is simi-
lar to putative MazG proteins from phages infecting
Synechococcus (including S-CRM01, S-SM2, and S-
ShM2), Prochlorococcus (including P-HM1, P-HM2, and
P-SSM2), and Bacillus (0305ϕ8-36), as well as to PA73
hypothetical protein ORF034 (Table 1). AH2 gp25 is
similar to putative Clostridium MazG proteins and to
the Burkholderia phage proteins ϕE255 gp37, BcepMu
gp06, and BcepB1A gp71. Both gp35 and gp25 are simi-
lar to E. coli MazG (100% and 99.76% probability, re-
spectively) (Additional file 1: Table S1 and Additional
file 2: Table S2). Because BCC bacteria found in soil and
water are likely to be nutrient-limited (similar tocyanobacteria), MazG proteins in BCC-specific phages
may help to facilitate infection in the environment. This
protein may also be involved in the unique plaque
phenotype of these phages, as the appearance of plaques
at low titre after >16 h incubation (at which time the
bacterial lawn appears intact) (Figure 1) suggests that
lysis of stationary phase cells may be occurring. Such a
trait would be especially important for clinical use, as
phage activity may be increased against stationary and/
or biofilm cells found in the CF lung.
MazG may also have an effect with respect to BCC
pathogenicity. Synthesis of ppGpp has been associated
with virulence in species such as Legionella, Listeria,
Pseudomonas, Salmonella, Mycobacterium, and Vibrio
(although the association in this species has been con-
troversial) [53-59]. In P. aeruginosa, relA mutants are
less virulent than the wildtype when tested in the
Drosophila melanogaster model [55] and relA spoT
mutants have reduced antibiotic tolerance [60]. Be-
cause MazG activity may mimic the effects of these
mutations, it is possible that phage-encoded MazG
could modulate the virulence and/or antibiotic toler-
ance of a lysogen. Further experiments are required to
determine if the putative KL1 and AH2 MazG proteins
have pyrophosphohydrolase activity, if these genes are
expressed in lysogens, and if MazG expression has an
effect on pathogenicity.
Convergent evolution
Although there have been relatively few papers pub-
lished on the subject, the occurrence of convergent evo-
lution in bacteriophages has been documented
previously. Most studies examine the phenomenon at
the molecular level by identifying identical base pair and
amino acid changes that occur in different phage
lineages under the same environmental conditions [61-
64]. Structural examples of convergent evolution, such
as the Caudovirales tail and the tectivirus pseudo-tail,
have been reviewed previously [65]. Given the ever-in-
creasing number of completed phage genome sequences,
it is expected that many more examples remain to be
identified (particularly at the whole genome level). Fur-
thermore, there are likely many examples in the litera-
ture of phages with similar phenotypes but dissimilar
genomes that have not explicitly been identified as
examples of convergent evolution, perhaps because they
exhibit what is considered to be a “standard” plaque
phenotype.
We predict that KL1 and AH2 represent examples of
phage convergent evolution at the whole genome level.
As discussed above, these two phages exhibit a plaque
phenotype that is both similar and unique in comparison
to all other BCC-specific phages that we have character-
ized previously. Because of these characteristics, KL1
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RFLP and genomic analysis. However, these phages ap-
pear to have convergently evolved because, as discussed
throughout, their genomes are almost entirely dissimilar
(Figure 4A). The relative rarity of this phenotype among
characterized phages of the BCC and other species may
be at least partially explained by sampling bias. Standard
phage isolation protocols most readily identify those
phages that have easily visible plaques on multiple hosts
after overnight incubation at a broad range of tempera-
tures. Phages such as KL1 and AH2 may be missed be-
cause of poorly visible plaques, incompatible hosts,
insufficient incubation times, incorrect temperatures,
titres that are too high or too low, overgrowth of bac-
teria, and/or competition by more rapidly lysing phages.
As novel phages continue to be isolated from environ-
mental samples using diverse bacterial hosts, the preva-
lence, distribution, and genetic basis of this phenotype
should become more apparent.
Several mechanisms could explain the delayed plaque
formation observed here, including long latent periods
or lysis inhibition (both with concomitantly large burst
sizes) [66], preferential infection of stationary phase
cells, or the gradual release of diffusible lytic enzymes
from small plaques. In order to differentiate these possi-
bilities, we performed one-step growth curves for both
phages using either exponential or stationary phase
C6433 as a host. Using a variation of a standard protocol
(described in Methods), the phage titres unexpectedly
remained stable (within one order of magnitude) over a
4 h period. Given the uninformative nature of these
results, we have thus far been unable to identify the
mechanism(s) responsible for the plaque phenotype.
Taking into consideration the very specific conditions
required for the observation of KL1 or AH2 plaques on
solid medium, we predict that the infection kinetics in li-
quid culture may be highly dependent upon host (both
strain and growth phase), incubation time, temperature,
titre, and potentially other factors (such as medium) that
are not accounted for using standard one-step growth
curve protocols.
Conclusions
A recent publication by Ceyssens et al. [67] provides an
interesting counterpoint to our study. While we identi-
fied KL1 and AH2 as phages that were phenotypically-
similar but genomically-distinct, this group analyzed a
set of Pseudomonas phages that were phenotypically-
distinct but genomically-similar. They found that, among
ϕKMV-like viruses with between 83-97% nucleotide
identity, there were significant differences observed with
respect to latent period, host range, and antibody re-
activity [67]. We have made similar observations with
our collection of BCC-specific phages: two phages canhave distinct phenotypes with respect to liquid clearing
and host range while at the same time having almost
identical genomes [22]. Taken together, the observations
made by Ceyssens et al. [67] and those discussed in this
study provide a) novel examples of both divergent and
convergent phage evolution and b) further evidence of
the broad diversity of phages that infect Gram-negative
opportunistic pathogens.
Methods
Bacterial strains and growth conditions
Burkholderia cenocepacia strains K56-2 and C6433, part
of the Burkholderia cepacia complex experimental strain
panel [68,69], were used for phage isolation and propa-
gation. Strains used for host range analysis (also part of
the panel) were acquired from the Belgium Coordinated
Collection of Microorganisms LMG Bacteria Collection
(Ghent, Belgium) and the Canadian Burkholderia cepa-
cia complex Research and Referral Repository (Vancou-
ver, BC). Strains were grown aerobically overnight at 30°
C on half-strength Luria-Bertani (½ LB) solid medium
or in ½ LB broth with shaking. Lysates for DNA isola-
tion were prepared from soft agar overlays made with ½
LB medium containing agarose instead of agar.
Phage isolation and propagation
KL1 and AH2 were isolated from sewage and Nandina
sp. soil, respectively, using standard extraction protocols
[26]. Environmental samples were incubated with shak-
ing at 30°C in a slurry of ½ LB broth, suspension
medium (SM) (50 mM Tris–HCl [pH 7.5], 100 mM
NaCl, 10 mM MgSO4, 0.01% gelatin solution), and BCC
liquid culture (K56-2 for KL1 isolation and C6433 for
AH2 isolation). Solids were pelleted by centrifugation
and the supernatant was filter-sterilized, plated in soft
agar overlays with the BCC strain used in the extraction,
and incubated overnight at 30°C and >24 h at room
temperature. Plaques were picked using a sterile Pasteur
pipette and transferred into 1 ml SM. Phage propagation
was performed using soft agar overlays: 100 μl liquid
culture and 100 μl phage stock (diluted in SM if neces-
sary) were incubated 20 min at room temperature,
mixed with 3 ml 0.7% ½ LB top agar, overlaid on a plate
of ½ LB solid medium, and incubated at 30°C and room
temperature until plaque formation was complete. High
titre stocks were made by transferring multiple plaques
into SM or by overlaying plates with SM and incubating
4–8 h at 4°C on a platform rocker.
Lysis characterization
Host ranges were performed using soft agar overlays (as
described above) or by spotting 10 μl aliquots of phage
stock (at multiple dilutions) onto a freshly-plated soft
agar overlay containing 100 μl liquid culture. K56-2 LPS
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using wildtype K56-2, RSF19 (wbxE::pRF201), XOA7
(waaL::pGPΩTp), XOA15 (wabR::pGPΩTp), XOA17
(wabS::pGPApTp), XOA8 (wabO::pGPΩTp), and CCB1
(waaC::pGPΩTp) (kindly provided by Miguel Valvano).
One-step growth curves were performed using a vari-
ation of a standard protocol [39]. One hundred microli-
ters of diluted phage lysate containing 106 PFU of KL1
or AH2 was mixed with 108 colony forming units of
C6433 (900 μl 5 h liquid culture [for exponential phase
curves] or 100 μl 16 h liquid culture diluted in 800 μl
spent ½ LB broth [for stationary phase curves]). The
suspension was incubated 15 minutes at 30°C, diluted
1:1000 into a flask containing ½ LB broth (exponential)
or spent ½ LB broth (stationary), and incubated without
shaking at 30°C. One milliliter samples were withdrawn
at one hour intervals for 4 h. Two 100 μl samples were
plated immediately in soft agar overlays with C6433.
One hundred microliters of chloroform was then added
to the sample, mixed 5 s on a vortexer, and separated by
centrifugation for 1 min at 13,000 rpm. Two 100 μl
chloroform-treated samples were then plated immedi-
ately in soft agar overlays with C6433. Plates were incu-
bated 48 h at 30°C prior to plaque enumeration.
Experiments were performed in triplicate for each condi-
tion (KL1 exponential or stationary phase, AH2 expo-
nential or stationary phase).
Electron microscopy
Filter-sterilized high titre stocks of KL1 and AH2 were
used for electron microscopy. 5–10 μl of phage lysate
was deposited onto a carbon-coated copper grid and
incubated 5 min at room temperature. Following adsorp-
tion of excess lysate onto a filter paper, the grids were
stained with 2% phosphotungstic acid for 2 min. Grids
were viewed using a Philips/FEI (Morgagni) transmission
electron microscope with charge-coupled device camera
(University of Alberta Department of Biological Sciences
Advanced Microscopy Facility).
DNA isolation, RFLP analysis, and sequencing
Phage DNA was isolated using polyethylene glycol pre-
cipitation and guanidine thiocyanate lysis. One hundred
milliliters of phage lysate (propagated on C6433) was
collected by overlaying turbid-clear or mottled ½ LB
agarose plates with SM and incubating at 4°C 4–8 h on
a platform rocker. Following the addition of chloroform,
debris in the lysate was pelleted by centrifugation for
10 min at 10,000 rcf and 4°C and the supernatant was
filter-sterilized with a Millex-HA 0.45 μm syringe dri-
ven filter unit (Millipore, Billerica, MA). Fifty milliliter
aliquots of the supernatant were incubated at 37°C
≥40 min with 10 μl DNase I, 10 μl DNase I buffer
and 6 μl RNase (Fermentas, Burlington, ON) to degradecontaminating bacterial nucleic acids. Following centrifu-
gation for 10 min at 4000 rcf and 4°C, phages in the
supernatant were precipitated in 1 M NaCl and 10%w/v
PEG 8000 at 4°C. The precipitated phages were pelleted
by centrifugation for 20 min at 10,000 rcf and 4°C and
resuspended in 1.6 ml SM. To eliminate residual DNase I
activity, the phage suspension was incubated at 37°C
10 min with 40 μl 20 mg/ml proteinase K. Following ex-
traction of the phages with an equal volume of chloro-
form and the addition of EDTA to 100 mM, ½ volume of
6 M guanidine thiocyanate was added to disrupt the cap-
sids and release the phage DNA. DNA was then purified
using the GENECLEAN Turbo Kit (Qbiogene, Irvine,
CA). Phage DNA was quantified using a NanoDrop ND-
1000 spectrophotometer (Thermo Scientific, Waltham,
MA).
RFLP analysis was performed using 5 μg of phage
DNA digested overnight at 37°C with EcoRI (Invitrogen,
Carlsbad, CA). For cos site screening, 5 μg EcoRI digests
were incubated 20 min at 80°C, cooled on ice, and sepa-
rated on 0.8% agarose gels in 1x TAE (pH 8.0). Bands
present only in the heated sample were excised from the
gel, purified using a GENECLEAN III kit (Qbiogene),
cloned into pJET1.2 (Fermentas), and sequenced to iden-
tify the cos site. Preliminary sequencing of EcoRI phage
DNA fragments cloned into pUC19 was performed as
described previously [19,29]. For complete genome se-
quencing, phage DNA was submitted to 454 Life
Sciences (Branford, CT) for pyrosequencing. The gen-
ome sequences of KL1 and AH2 have been deposited in
GenBank with the accession numbers JF939047 and
JN564907. Sequence start sites for these files were
chosen based on alignment with PA73 for KL1 and at
the cos site for AH2.
Bioinformatics analysis
Annotation of the genome sequences and determination
of GC contents were performed using GeneMark (http://
exon.biology.gatech.edu/gmhmm2_prok.cgi) [70]. Man-
ual annotations were performed for KL1 5 (encoding
Rz1) and KL1 19/AH2 55 (encoding translationally-
frameshifted tail proteins). Homology searches and con-
served domain searches were performed using HHpred
(http://toolkit.tuebingen.mpg.de/hhpred) [71] and NCBI’s
BLASTN/BLASTP (for full genomes and individual pro-
teins, respectively) (http://blast.ncbi.nlm.nih.gov) [72]
and Conserved Domain Search (http://www.ncbi.nlm.
nih.gov/Structure/cdd/wrpsb.cgi) [73]. FSFinder was
used for translational frameshift identification (http://
wilab.inha.ac.kr/fsfinder) [74]. Mfold was used for stem-
loop structure identification (http://mfold.rna.albany.
edu/?q=mfold) [75]. Sequence comparisons were visua-
lized using Circos (http://circos.ca) [76] and PROmer
(http://mummer.sourceforge.net) [77] with the following
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minmatch = 6. Lysis protein analysis was performed using
TMHMM for transmembrane region identification (http://
www.cbs.dtu.dk/services/TMHMM) [78] and LipoP for sig-
nal peptidase II cleavage site identification (http://www.cbs.
dtu.dk/services/LipoP) [79].
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